Snyder Mark Howard - Insider Non-Derivative Transactions at HALOZYME THERAPEUTICS, INC. (HALO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 16, 2024, Snyder Mark Howard's relationship to HALOZYME THERAPEUTICS, INC. (HALO) is Officer (SVP, GENERAL COUNSEL), and currently has 14,257 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other HALO insiders.
Data Source: SEC.
Snyder Mark Howard - Insider Non-Derivative Transactions of HALO Common Stock
Snyder Mark Howard - Insider Non-Derivative Transactions at HALO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 17, 2024 | F -- (Common Stock) | 2577 | 36.1 | 11680 |
| Feb 17, 2024 | M -- (Common Stock) | 4796 | 0 | 14257 |
| Jan 4, 2024 | F -- (Common Stock) | 2957 | 35.78 | 9461 |
| Jan 4, 2024 | M -- (Common Stock) | 7611 | 0 | 12418 |
| Jan 4, 2023 | F -- (Common Stock) | 2804 | 55.13 | 4807 |
| Jan 4, 2023 | M -- (Common Stock) | 7611 | 0 | 7611 |